🔎 Trials Near Me

Gara Jalqabaatti › Mesothelioma › Texas

Qorannoo klinikaalii Mesothelioma Texas keessatti

Qorannoo 19 Mesothelioma f Texas keessatti hirmaatuu jiru.

Magaalota Texas keessatti

Takkalaa qorannoo (Ingiliffa)

SW-682 in Advanced Solid Tumors

  • Mary Crowley Research Center US Oncology, Dallas
  • U.T. MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06251310

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

  • Baylor St Lukes, Houston
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05932199

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • START Dallas Fort Worth, Fort Worth
  • MD Anderson, Houston
  • NEXT Oncology Houston, Houston
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07277413

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07705334

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

  • NEXT Oncology - Austin, Austin
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06566079

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

  • The University of Texas MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04969315

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05732831

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • Ut Southwestern, Dallas
  • Texas Oncology - DFW, Fort Worth
  • MDACC, Houston
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT05245500

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Texas Oncology, Abilene
  • Texas Oncology - Central / South Texas, Austin
  • Mary Crowley Cancer Research, Dallas
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06710756

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

  • MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT05568680

CT-95 in Advanced Cancers Associated With Mesothelin Expression

  • Context Investigational Site, San Antonio
  • Context Investigational Site, San Antonio
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Wax-2026 · NCT06756035

A 2-part Phase 1/2 Open-label Trial on ODM-212

  • NEXT Oncology, Irving
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Cam-2026 · NCT07563738

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

  • MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06362369

A Study of VET3-TGI in Patients With Solid Tumors

  • Mary Crowley Cancer Research, Dallas
  • University of Texas MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Elb-2026 · NCT06444815

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT04665206

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • The University of Texas MD Anderson Cancer Center (site 127), Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Mud-2025 · NCT03556228

A Study of NX-1607 in Adults With Advanced Malignancies

  • MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Hag-2024 · NCT06452160

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.